In Silico Screening and In Vitro Assessment of Natural Products with Anti-Virulence Activity against Helicobacter pylori

Molecules. 2021 Dec 21;27(1):20. doi: 10.3390/molecules27010020.

Abstract

Helicobacter pylori is one of the most frequent human pathogens and a leading etiological agent of various gastric diseases. As stringent response, coordinated by a SpoT protein, seems to be crucial for the survivability of H. pylori, the main goal of this article was to use in silico computational studies to find phytochemical compounds capable of binding to the active site of SpoT from H. pylori and confirm the ability of the most active candidates to interfere with the virulence of this bacterium through in vitro experiments. From 791 natural substances submitted for the virtual screening procedure, 10 were chosen and followed for further in vitro examinations. Among these, dioscin showed the most interesting parameters (the lowest MIC, the highest anti-biofilm activity in static conditions, and a relatively low stimulation of morphological transition into coccoids). Therefore, in the last part, we extended the research with a number of further experiments and observed the ability of dioscin to significantly reduce the formation of H. pylori biofilm under Bioflux-generated flow conditions and its capacity for additive enhancement of the antibacterial activity of all three commonly used antibiotics (clarithromycin, metronidazole, and levofloxacin). Based on these results, we suggest that dioscin may be an interesting candidate for new therapies targeting H. pylori survivability and virulence.

Keywords: Bioflux; Helicobacter pylori; alternative therapy; biofilm; coccoid forms; dioscin; molecular docking; phytotherapy; virulence.

MeSH terms

  • Amino Acid Sequence
  • Anti-Bacterial Agents / chemistry*
  • Anti-Bacterial Agents / pharmacology
  • Biofilms / drug effects
  • Biological Products / chemistry*
  • Catalytic Domain
  • Clarithromycin / pharmacology
  • Diosgenin / analogs & derivatives*
  • Diosgenin / chemistry
  • Diosgenin / pharmacology
  • Drug Evaluation, Preclinical
  • Helicobacter Infections / drug therapy*
  • Helicobacter pylori / drug effects*
  • Humans
  • Levofloxacin / pharmacology
  • Metronidazole / pharmacology
  • Microbial Sensitivity Tests
  • Molecular Docking Simulation
  • Protein Binding
  • Protein Conformation
  • Pyrophosphatases / chemistry*
  • Virulence / drug effects*

Substances

  • Anti-Bacterial Agents
  • Biological Products
  • Metronidazole
  • dioscin
  • Levofloxacin
  • Pyrophosphatases
  • Clarithromycin
  • Diosgenin